The program subsidizes schools to develop courses on non-animal alternative models, including 3D mapping, digital imaging, ...
Cancer vaccines' efficacy can be tested on an organ-on-a-chip platform that replicates age-related immune decline.
The former chief executive of Nexperia, a Dutch chipmaker, said Dutch officials had known for years that the company’s ...
Validate cross-chip data paths in multi-die packages and evaluate the impact on power, performance, and reliability.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Sandia National Laboratories welcomed a new supercomputer this month, one that could reshape simulations and ensure the ...
News-Medical.Net on MSN
Organ-on-a-chip system reveals how aging weakens vaccine-driven anti-cancer immunity
Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates ...
RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Nova Minerals Limited ...
EDGE FGT: Cell type-specific tools for the study of gene function in spongesScott Nichols, College of Natural Sciences and ...
Deep vertical holes and re-entrant features challenge the best metrology methods.
The field of in vitro modeling of organogenesis and disease has witnessed remarkable progress due to innovations in stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results